Infobird (NASDAQ:IFBD) vs. Clarivate (NYSE:CLVT) Head-To-Head Survey

Infobird (NASDAQ:IFBD) and Clarivate (NYSE:CLVT) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, institutional ownership and earnings.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Infobird and Clarivate, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Infobird	1	0	0	0	1.00
Clarivate	3	5	0	0	1.63

Clarivate has a consensus price target of $3.22, indicating a potential upside of 40.16%. Given Clarivate’s stronger consensus rating and higher possible upside, analysts clearly believe Clarivate is more favorable than Infobird.

Insider & Institutional Ownership

2.9% of Infobird shares are owned by institutional investors. Comparatively, 85.7% of Clarivate shares are owned by institutional investors. 35.5% of Infobird shares are owned by company insiders. Comparatively, 23.2% of Clarivate shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility and Risk

Infobird has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500.

Earnings & Valuation

This table compares Infobird and Clarivate”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Infobird	$8.71 million	0.60	-$2.10 million	N/A	N/A
Clarivate	$2.46 billion	0.60	-$201.10 million	($0.30)	-7.65

Infobird has higher earnings, but lower revenue than Clarivate.

Profitability

This table compares Infobird and Clarivate’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Infobird	N/A	N/A	N/A
Clarivate	-8.19%	8.30%	3.63%

Summary

Clarivate beats Infobird on 6 of the 11 factors compared between the two stocks.

About Infobird

Infobird Co., Ltd, through its subsidiaries, operates as a software-as-a-service (SaaS) provider of artificial intelligence (AI) enabled customer engagement solutions in the People's Republic of China. The company offers customer relationship management cloud-based services, such as SaaS and business process outsourcing services to its clients. It also provides AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to enable its clients to monitor, benchmark, and enhance the performances of agents; consumer product and retail store digitalization solutions; and other services, including software license selling, data analysis, and other professional services. The company serves corporate clients in the finance, education, public services, healthcare, and consumer products industries. Infobird Co., Ltd was founded in 2001 and is based in Beijing, the People's Republic of China.

About Clarivate

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.